Evidence map›Paper›PMID 38722529›Full record

ArticleTherapeutic innovation & regulatory science2024

Good Statistical Monitoring: A Flexible Open-Source Tool to Detect Risks in Clinical Trials.

George Wu, Spencer Childress, Zhongkai Wang, Matt Roumaya, Colleen McLaughlin Stern, Chelsea Dickens, Jeremy Wildfire

Abstract read
In one paragraph

Article in Therapeutic innovation & regulatory science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

George WuGilead Sciences Inc., 333 Lakeside Dr, Foster City, CA, 94404, USA. George.Wu@gilead.com.ORCID 0009-0003-5984-6457
Spencer ChildressGilead Sciences Inc., 333 Lakeside Dr, Foster City, CA, 94404, USA.
Zhongkai WangGilead Sciences Inc., 333 Lakeside Dr, Foster City, CA, 94404, USA.
Matt RoumayaAtorus Research, Newtown Square, Harrisburg, PA, USA.
Colleen McLaughlin SternAtorus Research, Newtown Square, Harrisburg, PA, USA.
Chelsea DickensAtorus Research, Newtown Square, Harrisburg, PA, USA.
Jeremy WildfireGilead Sciences Inc., 333 Lakeside Dr, Foster City, CA, 94404, USA.

Funding

Gilead Sciences Gilead Sciences
6 · The paper itself

Abstract

backgroundRisk-based quality management is a regulatory-recommended approach to manage risk in a clinical trial. A key element of this strategy is to conduct risk-based monitoring to detect potential risks to critical data and processes earlier. However, there are limited publicly available tools to perform the analytics required for this purpose. Good Statistical Monitoring is a new open-source solution developed to help address this need.

methodsA team of statisticians, data scientists, clinicians, data managers, clinical operations, regulatory, and quality compliance staff collaborated to design Good Statistical Monitoring, an R package, to flexibly and efficiently implement end-to-end analyses of key risks. The package currently supports the mapping of clinical trial data from a variety of formats, evaluation of 12 key risk indicators, interactive visualization of analysis results, and creation of standardized reports.

resultsThe Good Statistical Monitoring package is freely available on GitHub and empowers clinical study teams to proactively monitor key risks. It employs a modular workflow to perform risk assessments that can be customized by replacing any workflow component with a study-specific alternative. Results can be exported to other clinical systems or can be viewed as an interactive report to facilitate follow-up risk mitigation. Rigorous testing and qualification are performed as part of each release to ensure package quality.

conclusionsGood Statistical Monitoring is an open-source solution designed to enable clinical study teams to implement statistical monitoring of critical risks, as part of a comprehensive risk-based quality management strategy.

Indexed as

Clinical Trials as TopicHumansResearch DesignRisk AssessmentRisk ManagementSoftwareInteractive graphicsRRisk-based monitoringRisk-based quality managementStatistical monitoring

Identifiers

PMID38722529
PMCPMC11335794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.